MDP Stock Overview
Engages in the real estate business. More details
Snowflake Score | |
---|---|
Valuation | 1/6 |
Future Growth | 0/6 |
Past Performance | 3/6 |
Financial Health | 3/6 |
Dividends | 0/6 |
Rewards
Risk Analysis
My Notes
Capture your thoughts, links and company narrative
Medcamp S.A. Competitors
Price History & Performance
Historical stock prices | |
---|---|
Current Share Price | zł0.43 |
52 Week High | zł0.77 |
52 Week Low | zł0.39 |
Beta | -7.95 |
1 Month Change | -14.00% |
3 Month Change | -20.07% |
1 Year Change | -27.12% |
3 Year Change | -77.72% |
5 Year Change | 79.17% |
Change since IPO | -96.12% |
Recent News & Updates
Recent updates
Shareholder Returns
MDP | PL Real Estate | PL Market | |
---|---|---|---|
7D | -3.8% | -2.6% | -2.6% |
1Y | -27.1% | -0.06% | -4.9% |
Return vs Industry: MDP underperformed the Polish Real Estate industry which returned -0.1% over the past year.
Return vs Market: MDP underperformed the Polish Market which returned -4.9% over the past year.
Price Volatility
MDP volatility | |
---|---|
MDP Average Weekly Movement | 8.4% |
Real Estate Industry Average Movement | 5.6% |
Market Average Movement | 4.9% |
10% most volatile stocks in PL Market | 8.7% |
10% least volatile stocks in PL Market | 3.2% |
Stable Share Price: MDP's share price has been volatile over the past 3 months compared to the Polish market.
Volatility Over Time: MDP's weekly volatility (8%) has been stable over the past year, but is still higher than 75% of Polish stocks.
About the Company
Founded | Employees | CEO | Website |
---|---|---|---|
n/a | n/a | Cezary Ziarkowski | medcampsa.pl |
Medcamp S.A. engages in the real estate business. The company also offers basic inorganic and organic chemicals; pharmaceutical substances; management consultancy services; financial services, such as fund management; engineering and related technical consultancy; and research and development services. Medcamp S.A. was formerly known as T2 Investment SA.
Medcamp S.A. Fundamentals Summary
MDP fundamental statistics | |
---|---|
Market cap | zł11.24m |
Earnings (TTM) | zł1.07m |
Revenue (TTM) | n/a |
10.5x
P/E Ratio0.0x
P/S RatioIs MDP overvalued?
See Fair Value and valuation analysisEarnings & Revenue
MDP income statement (TTM) | |
---|---|
Revenue | zł0 |
Cost of Revenue | -zł18.42k |
Gross Profit | zł18.42k |
Other Expenses | -zł1.05m |
Earnings | zł1.07m |
Last Reported Earnings
Jun 30, 2024
Next Earnings Date
n/a
Earnings per share (EPS) | 0.041 |
Gross Margin | 0.00% |
Net Profit Margin | 0.00% |
Debt/Equity Ratio | 6.3% |
How did MDP perform over the long term?
See historical performance and comparisonCompany Analysis and Financial Data Status
Data | Last Updated (UTC time) |
---|---|
Company Analysis | 2024/12/22 07:27 |
End of Day Share Price | 2024/12/20 00:00 |
Earnings | 2024/06/30 |
Annual Earnings | 2023/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
Package | Data | Timeframe | Example US Source * |
---|---|---|---|
Company Financials | 10 years |
| |
Analyst Consensus Estimates | +3 years |
|
|
Market Prices | 30 years |
| |
Ownership | 10 years |
| |
Management | 10 years |
| |
Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
Medcamp S.A. is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
Analyst | Institution |
---|